Month: April 2020

We present annual information approved by Annual General Meeting of Shareholders of Panevėžio statybos trestas AB on 29 April 2020.Dalius GesevičiusManaging DirectorPhone: (+370 45) 505 503Attachments19-PST-Bendroves -Atskiros ataskaitos 2019 EN19-PST-Konsoliduotos ataskaitos 2019 ENG

Teikiame 2020 m. balandžio 29 d. AB „Panevėžio statybos trestas“ eiliniame visuotiniame akcininkų susirinkime patvirtintą metinę informaciją.Dalius GesevičiusAB PST Generalinis direktoriusInformacijaTel.: 8 45 505 503;Priedai19-PST-Bendroves-Atskiros ataskaitos 2019 LT19-PST-Konsoliduotos ataskaitos 2019 LT

Saga Furs Oyj, yhtiökokouksen päätökset, 29.4.2020 klo 14.30 Saga Furs Oyj:n 29.4.2020 kokoontunut yhtiökokous vahvisti yhtiön tilinpäätöksen tilikaudelta 1.11.2018-31.10.2019. Yhtiökokous hyväksyi hallituksen ehdotuksen olla jakamatta osinkoa osakkeenomistajille ja hallitus valtuutettiin päättämään myöhemmin enintään 0,50 euron osingosta osaketta kohden. Valtuutus on voimassa seuraavaan varsinaiseen yhtiökokoukseen asti.Palkitsemispolitiikka esitettiin yhtiökokoukselle. Koska yhtiökokous ei kannattanut esitettyä palkitsemispolitiikkaa, se esitetään uudelleen valmisteltuna yhtiökokoukselle viimeistään seuraavassa varsinaisessa yhtiökokouksessa.Saga Fursin hallitukseen valittiin Kenneth Ingman (Marcus Nordmyr), Jari Isosaari (Arto Isopahkala), Lasse Joensuu (Markku Kujanen), Anders Kulp (Daniel Blomqvist), Virve Kuusela (Marja Tiura),...

Beslut vid Saga Furs Oyj:s bolagsstämma, 29.4.2020 kl. 14.30 Saga Furs Oyj:s bolagsstämma, som sammankallades den 29.4.2020, fastställde bolagets bokslut för räkenskapsperioden 1.11.2018–31.10.2019. Bolagsstämman godkände styrelsens förslag att inte utbetala dividend till aktieägarna, och styrelsen bemyndigades att senare besluta om en dividendutdelning på högst 0,50 euro per aktie. Bemyndigandet är i kraft fram till nästa ordinarie bolagsstämma.Ersättningspolicyn presenterades för bolagsstämman. Eftersom bolagsstämman inte omfattade den presenterade ersättningspolicyn, kommer en reviderad policy att presenteras för bolagsstämman senast vid nästa ordinarie bolagsstämma.Till Saga Furs Oyj:s styrelse valdes Kenneth Ingman (Marcus Nordmyr), Jari Isosaari (Arto Isopahkala), Lasse Joensuu (Markku Kujanen), Anders Kulp (Daniel Blomqvist), Virve...

SAN DIEGO, April 29, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that it will report first quarter 2020 financial results after the close of U.S. financial markets on Monday, May 4, 2020. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update.The live call may be accessed by dialing 877-516-3514 for domestic callers and 281-973-6129 for international callers and entering the conference code: 2085246. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.kuraoncology.com.                                                                                             About...

SOUTH ORANGE, NJ, April 29, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its first quarter 2020 financial results on Wednesday, May 6, 2020 and will host a conference call that same day at 4:30 PM ET, during which management will discuss the company’s financial results and provide a general business overview.Participants may dial into the following number to access the call: 1-888-220-8474. International callers may use 1-323-794-2588. Please ask to be joined into the Nephros conference call. A replay of the call can be accessed until May 20, 2020 at 1-844-512-2921 or 1-412-317-6671 for international...

JOHNS CREEK, Ga. , April 29, 2020 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering multi-regional less-than-truckload (LTL), non-asset truckload, expedited and logistics services, today reported first quarter 2020 financial results.  Diluted earnings per share in the quarter were $1.06 compared to $0.85 in the first quarter of 2019.Highlights from the first quarter operating results were as follows:First Quarter 2020 Compared to First Quarter 2019 ResultsRevenue was $446.4 million, an 8.7% increaseOperating income was $38.8 million, a 35.4% increaseOperating ratio of 91.3 compared to 93.0LTL shipments per workday rose 2.3%LTL tonnage per workday increased by 4.0%LTL revenue per hundredweight increased 3.1%LTL revenue per shipment rose 4.9% to $241.61“First quarter results were marked by shipment...

CAMBRIDGE, Mass., April 29, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced multiple data presentations at the American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting taking place virtually on May 12-15, 2020.The ASGCT abstracts are now available at https://www.asgct.org/.Details for the oral presentations are as follows:Title: Development of AAV-based RNAi Therapeutics for Huntington’s DiseaseSession: Scientific SymposiumDate/time: May 12, 2020, 9:18-9:45 a.m. ETTitle: Engineering Viral Protein Ratios to Impact AAV PotencySession: AAV Vectors – Clinical Studies IIDate/time: May 13, 2020, 5:00-5:15 p.m. ETTitle: Lac Repressor Inducible Control of AAV Capsid...

STRASBURG, Va., April 29, 2020 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC) reported unaudited consolidated net income of $1.7 million, or $0.34 per diluted share, for the first quarter of 2020, which resulted in a return on average assets of 0.85% and a return on average equity of 8.72%. This was a $556 thousand, or 25%, decrease compared to net income for the first quarter of 2019, which totaled $2.3 million or $0.46 per diluted share, and a return on average assets of 1.21% and a return on average equity of 13.47%.Highlights for the first quarter of 2020:Provision for loan losses totaled $900 thousand, compared to no provision in Q1 2019Cash and unencumbered securities totaled $133.4 million, or 16% of assetsNonperforming assets decreased to 0.19% of assetsLoans increased $30.8...

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Wednesday, May 6, 2020. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, Daniel Luckshire, Chief Financial Officer, and Dr. Dennis Hruby, Chief Scientific Officer.A live webcast of the call will be available on the Company’s website at www.siga.com under the ‘Events & Presentations’ tab in the Investor Relations section, or by clicking here. Participants may also access the call, by dialing (877) 407-6184 for domestic callers or (201) 389-0877 for international callers. Please log in approximately...